Vyant Bio
Vyant Bio is a New Jersey-based biotechnology company that researches and develops proprietary genomic tests for cancer treatment.
Business Model:
Revenue: $2.2M
Employees: 11-50
Industries / Tags:
Detailed Vyant Bio Information
Geographic Data
Address: 2 Executive Campus
City: Cherry Hill
State: NJ
Zip: 08002
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$18M
Raised Total:$48M
Social
Metrics
9,259,342Website Global Rank
272Website Monthly Traffic
Twitter Followers
Description
Vyant Bio is a New Jersey-based biotechnology company that researches and develops proprietary genomic tests for cancer treatment.
Contact Phone:
Contact Email:
Vyant Bio went public on 6/6/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/6/2013
Ticker Symbol:
VYNT
Amount Raised:
$15M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2018 | Convertible Note | $2.6M | 11/2020 | Post-IPO Equity | $3.5M | 3/2017 | Debt | $6M | 2/2021 | Post-IPO Equity | $17.5M | 1/2021 | Post-IPO Equity | $10M | 1/2019 | Post-IPO Equity | $3M | 5/2016 | Post-IPO Equity | $5M | 9/2016 | Unattributed | $5.5M | 11/2010 | Venture Round | $6.6M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2021 | StemoniX | |
| 8/2020 | StemoniX | |
| 8/2017 | vivoPharm Pty Ltd | |
| 8/2015 | Response Genetics Inc. | |
| 8/2014 | BioServe Biotechnologies (India) | |
| 7/2014 | Gentris |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
